Severe and fatal COVID-19 is characterized by increased circulating GLP-1 and PCT and modulated by T2D
Description
CONCLUSIONS: The persistent joint increase of endogenous GLP-1 and PCT in severe and fatal COVID-19 suggests a role of concomitant bacterial infection in disease exacerbation. Early elevation of endogenous GLP-1 may serve as new biomarker of COVID-19
